Y-mabs appoints oncology executive mary tagliaferri, m.d. to its board of directors

Dr. tagliaferri brings deep biopharmaceutical industry expertise and a successful track record in oncology therapeutic development dr. tagliaferri brings deep biopharmaceutical industry expertise and a successful track record in oncology therapeutic development

YMAB Ratings Summary

YMAB Quant Ranking